종양학 정보 시스템 시장은 2023-2030년간 7.4%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 44억 5,000만 달러에 달할 것으로 예상됩니다.
이 보고서는 광범위한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 억제요인, 시장 성장 촉진요인 및 과제에 대한 분석을 제공합니다.
이 시장의 성장은 암 유병률 증가, 암 치료의 디지털화, 암 치료 비용 절감에 대한 요구 증가, 전자 의료 기록(EHR) 도입 증가, 환자 정보 및 데이터 관리의 간소화에 대한 수요 증가에 힘입어 성장하고 있습니다.
그러나 종양학 정보 시스템의 높은 비용과 데이터 보안 및 개인 정보 보호에 대한 우려로 인해 이 시장의 성장이 제한되고 있습니다. 또한, 암 치료에 정밀의료의 통합과 신흥국에서의 잠재력 증가는 이 시장 진출기업들에게 큰 성장 기회를 제공할 것으로 예상됩니다.
그러나 종양학 정보 시스템 도입 및 구현에 대한 장벽과 종양학 정보 시스템 사용에 대한 교육 및 훈련에 대한 추가 요구 사항은 시장 성장을 제한하는 주요 과제입니다.
(주 : 주요 기업 5개사에 대한 SWOT 분석이 보고서에 게재 됩니다.)
Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030
The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.
However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.
However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.
An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.
Oncology Information Systems Market Assessment-by Offering
Oncology Information Systems Market Assessment-by Application
Oncology Information Systems Market Assessment-by End User
Note: Other end users primarily include research institutes and government institutions.
Oncology Information Systems Market Assessment-by Geography
(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)